Governance body
Strategic Committee
Representative of each partner insitution
- Philippe CASSAGNAU, Vice President of the Research Commission of the Academic Council of Claude Bernard University Lyon 1 (UCBL)
- Frédéric CAROFF, Chief Executive Officer of HEPHAISTOS-Pharma
- Alexandre PACHOT, Director of the Health Research Department of the Hospices Civils de Lyon (HCL)
- Jean-Yves BLAY, General Director of the Léon Bérard Center (CLB)
- Dominique PELLA, Director of the AURA Delegation of INSERM
- Laurent BARBIERI, Regional Delegate of the CNRS
Steering Committee
Scientific and Technical Manager of each partner institution
- Charles DUMONTET, Deputy Director and Head of the Oncopharmacology Team at the Lyon Cancer Research Center (CRCL) & Professor of Hematology at UCBL.
- Frédéric CAROFF, Chief Executive Officer of HEPHAISTOS-Pharma
- Benoît YOU, Head of the Medical Oncology Department at HCL
- David PEROL, Director of Clinical Research and Innovation at the CLB
Scientific Advisory Board (SAB)
External international scientific experts
- Mihai NETEA, Immunologist designing the innate immune response, Netherlands
- Georges DEMETRI, Sarcoma specialist, USA
- Mervyn SINGER, Specialist in intensive care for infectious diseases, UK
- Lillian SIU, Oncologist specialized in phase I trials, Canada
- Vasileios ASKOXYLAKIS, Global head of early clinical development in oncology at Servier Pharmaceuticals, USA
Coordination
Project leader: Pr. Charles DUMONTET
- Head of the Oncopharmacology team at the Lyon Cancer Research Center (CRCL)
- Deputy director of CRCL
- Professor of Hematology at UCBL.
- Hospital Doctor at HCL
- Vice President of Research at HCL
Project manager: Dr. Juliette HUMEAU
